Ac1 - Outcome of New Drug Negotiation Process in Italy: Approval Conditions (2015-2018)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php76 - Analysis of Approval Timing for 89 New Drugs in Italy From January 2015 to May 2018

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php34 - Time Analysis of the Drug Approval Process in Europe

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

New Drug Approval Probability Model in Phased Clinical Trials

American Journal of Health Research
2013English

New FDA Drug Approval Policies and HIV Vaccine Development.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1990English

Ac1

2020English

Debating Drug Approval Decisions

Cancer Discovery
Oncology
2013English

The Effects of Anchor Points and Reference Points on Negotiation Process and Outcome

Organizational Behavior and Human Decision Processes
Human Resource ManagementApplied PsychologyOrganizational Behavior
1997English

From the FDA: New Class of Asthma Drug Receives Advisory Approval

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Supplement of AC1

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy